Global Artificial Urinary Sphincter Market Growth 2026-2032

October 2026 | 90 pages | ID: G503CDFE123BEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Artificial Urinary Sphincter market size is predicted to grow from US$ 50.87 million in 2025 to US$ 68.46 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.

An Artificial Urinary Sphincter is a surgically implanted urological device that uses an artificial closure mechanism to control urethral opening and closing and restore continence in patients with intrinsic urinary sphincter deficiency. Commercial products are primarily hydraulic systems comprising a urethral occlusion cuff, a patient-operated control pump and a pressure-regulating balloon or integrated fluid reservoir. Emerging products are introducing electromechanical actuators, sensors and external programming capabilities. The principal clinical application is moderate-to-severe male stress urinary incontinence following prostate surgery, with selected use in neurogenic, traumatic and other complex sphincter deficiencies. Artificial Urinary Sphincters occupy the implantable medical-device segment of the urinary-incontinence treatment value chain. Upstream inputs include medical-grade silicone, precision pumps and valves, implantable electronic components, surface coatings, sterile packaging and contract manufacturing, while downstream participants include specialist urology centers, tertiary hospitals, implanting surgeons and healthcare reimbursement systems. Product value is determined by continence performance, implant durability, infection and erosion risk, surgical convenience, postoperative adjustability and long-term revision requirements.

Key Findings

Global Artificial Urinary Sphincter shipments reached approximately 13,000 systems in 2025

The weighted average manufacturer price was approximately US$4,000 per system in 2025

Fixed-pressure hydraulic systems remained the largest commercial product segment

Male post-prostate treatment urinary incontinence remained the principal clinical application

Market Trends

Artificial Urinary Sphincters are evolving from conventional fixed-pressure hydraulic structures toward adjustable-pressure, pressure-responsive and actively controlled electromechanical systems. Mature products continue to rely primarily on a manually operated scrotal pump and a circumferential urethral cuff to restore urinary continence. Newer systems increasingly emphasize simplified implantation, fewer intraoperative connections, broader cuff-size availability, hydrophilic or antimicrobial surface treatments and improved postoperative pressure optimization. Rigicon has developed pressure-responsive balloon products, Promedon provides postoperative hydraulic adjustment, while investigational systems from UroMems and Carvolix introduce active electronic control or external remote operation. The industry is moving from standardized mechanical continence restoration toward personalized pressure management and digitally enabled implants, although conventional hydraulic systems are expected to remain the commercial mainstream over the short to medium term.

Market Dynamics

Drivers

Market demand is primarily generated by persistent moderate-to-severe stress urinary incontinence following radical prostatectomy and other prostate treatments. Clinical guidelines continue to recognize Artificial Urinary Sphincters as an important treatment option for suitable patients, particularly when conservative management or less invasive surgical procedures fail to deliver adequate continence improvement. Implanted systems also have finite mechanical service lives. Some patients require system replacement or revision because of component failure, infection, urethral erosion or declining continence performance, creating recurring demand from the installed patient base.

Restraints

Market expansion is constrained by a relatively limited eligible patient population, the concentration of implantation procedures in specialist centers and the requirement for patients to have sufficient manual dexterity and cognitive ability to operate conventional control pumps. High total treatment costs, uneven reimbursement and a shortage of trained implanting surgeons limit penetration outside mature healthcare markets. Male urethral slings, adjustable periurethral balloons and conservative continence-management approaches also divert some patients with mild-to-moderate leakage. Long-term risks, including infection, urethral erosion, mechanical failure and repeat surgery, further influence patient acceptance and hospital purchasing decisions.

Opportunities

Future market opportunities are concentrated among clinically eligible patients who have not received effective surgical treatment and remain dependent on absorbent pads or conservative management, as well as in emerging regions where reconstructive urology capabilities are improving. Adjustable hydraulic systems can correct insufficient compression or excessive cuff pressure after implantation, while active electromechanical systems may reduce operational difficulty and limit continuous urethral compression. Surgeon training, implantation support, postoperative pressure adjustment, revision components and long-term patient follow-up will create additional value beyond initial device sales. Smart implants could establish a new premium technology segment if pivotal clinical trials and regulatory approvals are successfully completed, although they are unlikely to replace established hydraulic systems in the near term.

Challenges

Manufacturers must maintain stable continence outcomes over long implantation periods while reducing infection, urethral erosion, tissue atrophy and mechanical revision risks. High-risk implantable-device regulation, demanding clinical evidence requirements and lengthy surgeon-adoption cycles make commercialization substantially more expensive than for conventional urological consumables. New entrants must demonstrate that adjustable or electronic systems provide clinically meaningful improvements rather than simply adding technical complexity. As electromechanical systems move closer to commercialization, battery life, hermetic sealing, software reliability, remote-control security and long-term tissue compatibility will become increasingly important competitive barriers.

Industry Chain Analysis

The upstream industry chain includes medical-grade silicone elastomers, polyurethane tubing, metallic connectors, miniature pumps and valves, pressure reservoirs, surface coatings, sensors, implantable batteries, electronic controllers, precision molding, sterile packaging and sterilization services. Components must comply with implant-grade biocompatibility, mechanical-fatigue, fluid-sealing and quality-traceability requirements. Raw materials account for only a limited proportion of total product value, while research and development, regulatory registration, clinical validation, low-volume precision manufacturing and post-market surveillance represent more significant cost and value components.

Midstream manufacturers are responsible for implant architecture, pressure-control mechanisms, cuff-sizing systems, assembly, sterilization and clinical support. Downstream value creation covers hospital procurement, surgeon training, implantation procedures, device activation, postoperative adjustment and long-term revision management. Artificial Urinary Sphincter procedures remain concentrated in experienced reconstructive urology centers, making direct manufacturer support and specialized distributor networks important commercial capabilities. Companies that support the full patient implantation lifecycle generally have greater long-term value-capture potential than suppliers relying solely on initial device sales.

Segment Insights

Fixed-pressure hydraulic systems continue to dominate the commercial market because of their long clinical history, mature surgical procedures and familiarity among implanting surgeons. Adjustable-pressure hydraulic systems represent a smaller segment but provide strategic value by allowing postoperative adjustment of urethral closure pressure and a more flexible balance between continence performance and tissue protection. Active electromechanical systems currently account for a minimal commercial share, as leading products remain in clinical development, but they represent the principal direction of long-term technology advancement.

By system architecture, three-component hydraulic devices continue to account for the majority of established demand, while integrated two-component systems seek to reduce surgical complexity by limiting the number of implanted components and intraoperative connections. By procedure type, primary implantation forms the underlying demand base, while complete system replacement and partial component revision generate recurring installed-base revenue. By clinical application, male post-prostate treatment stress urinary incontinence accounts for the largest share, while neurogenic, female and other complex cases remain smaller specialist applications.

Downstream Market Opportunities

The primary downstream opportunity remains male patients with persistent moderate-to-severe stress urinary incontinence following radical prostatectomy, radiotherapy or other prostate treatments, particularly those who do not achieve adequate continence improvement through pelvic-floor rehabilitation, medication, bulking agents or male urethral slings. Specialist hospitals can expand implantation volumes through standardized patient selection, dedicated continence clinics, stronger surgeon training and structured long-term follow-up. Smart or remotely controlled systems may provide treatment options for patients who have difficulty operating conventional scrotal pumps, although their long-term safety and reliability must be validated before broad clinical adoption.

Regional Insights

North America and Western Europe represent the principal mature markets. These regions have established reconstructive urology centers, clearer recognition within clinical guidelines and relatively developed reimbursement pathways. Their large historical installed bases also generate replacement and revision demand. North America and Western Europe are the main launch regions for new hydraulic and electromechanical technologies because manufacturers can work with experienced clinical investigators and high-volume treatment centers. Nevertheless, demand remains concentrated in a limited number of specialist hospitals rather than being broadly distributed across general healthcare institutions.

Asia-Pacific, Latin America and the Middle East offer long-term penetration opportunities. Market development depends on regulatory registration, reimbursement coverage, surgeon education and the establishment of referral pathways for post-prostate treatment incontinence. Domestic product commercialization in China remains at an early stage, while imported systems face constraints related to pricing, registration and specialist clinical support. Growth in these regions is therefore more likely to be driven gradually by major tertiary hospitals and regional specialist centers than by rapid mass-market adoption.

Competitive Landscape

The commercial market is concentrated among a limited number of manufacturers with complete implant systems and established clinical-validation capabilities. Boston Scientific maintains a mature-product advantage through the long clinical history and large installed base of the AMS 800. ZSI Surgical Implants differentiates through a preconnected and prefilled two-component design. Rigicon has developed both conventional hydraulic and pressure-responsive configurations, while Promedon emphasizes postoperative pressure adjustability. The next competitive layer consists of investigational smart implants. UroMems is advancing the automated UroActive system through pivotal clinical development, while Carvolix is developing the externally controlled Artus platform.

Competition is divided between established suppliers that rely on hydraulic-system reliability, surgeon familiarity and clinical-support networks, and emerging developers seeking differentiation through adjustability, automated control and reduced dependence on manually operated pumps. Future competitive positions will increasingly depend on long-term clinical outcomes, regulatory progress, revision rates, surgeon-training capabilities and the total cost of managing patients throughout the implant lifecycle.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “Artificial Urinary Sphincter Industry Forecast” looks at past sales and reviews total world Artificial Urinary Sphincter sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Urinary Sphincter sales for 2026 through 2032. With Artificial Urinary Sphincter sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Urinary Sphincter industry.

This Insight Report provides a comprehensive analysis of the global Artificial Urinary Sphincter landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Urinary Sphincter portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Urinary Sphincter market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Urinary Sphincter and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Urinary Sphincter.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Urinary Sphincter market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

  • Non-Adjustable
  • Percutaneously Adjustable
  • Electronically Programmable

Segmentation by Actuation Mechanism:

  • Passive Hydraulic Compression
  • Active Electromechanical Occlusion
  • Others

Segmentation by Clinical Application:

  • Male Post-Prostate Treatment Stress Urinary Incontinence
  • Male Neurogenic, Traumatic and Other Sphincter Deficiency
  • Female and Pediatric Severe Stress Urinary Incontinence
  • Others

Segmentation by Application:

  • Public and University Hospitals
  • Private Hospitals
  • Specialty Urology Centers and Ambulatory Surgical Centers
  • Others

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Boston Scientific Corporation
  • ZSI Surgical Implants S.R.L.
  • Rigicon, Inc.
  • Promedon S.A.
  • GT Urological
  • UroMems S.A.S.
  • Carvolix (formerly Affluent Medical)
  • RELIEF srl
  • Myopowers

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Artificial Urinary Sphincter market?
  • What factors are driving Artificial Urinary Sphincter market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Artificial Urinary Sphincter market opportunities vary by end market size?
  • How does Artificial Urinary Sphincter break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Artificial Urinary Sphincter Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Artificial Urinary Sphincter by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Artificial Urinary Sphincter by Country/Region, 2021, 2025 & 2032
2.2 Artificial Urinary Sphincter Segment by Type
  2.2.1 Non-Adjustable
  2.2.2 Percutaneously Adjustable
  2.2.3 Electronically Programmable
  2.2.4 Artificial Urinary Sphincter Sales by Type
    2.2.4.1 Global Artificial Urinary Sphincter Sales Market Share by Type (2021-2026)
    2.2.4.2 Global Artificial Urinary Sphincter Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global Artificial Urinary Sphincter Sale Price by Type (2021-2026)
2.3 Artificial Urinary Sphincter Segment by Actuation Mechanism
  2.3.1 Passive Hydraulic Compression
  2.3.2 Active Electromechanical Occlusion
  2.3.3 Others
  2.3.4 Artificial Urinary Sphincter Sales by Actuation Mechanism
    2.3.4.1 Global Artificial Urinary Sphincter Sales Market Share by Actuation Mechanism (2021-2026)
    2.3.4.2 Global Artificial Urinary Sphincter Revenue and Market Share by Actuation Mechanism (2021-2026)
    2.3.4.3 Global Artificial Urinary Sphincter Sale Price by Actuation Mechanism (2021-2026)
2.4 Artificial Urinary Sphincter Segment by Clinical Application
  2.4.1 Male Post-Prostate Treatment Stress Urinary Incontinence
  2.4.2 Male Neurogenic, Traumatic and Other Sphincter Deficiency
  2.4.3 Female and Pediatric Severe Stress Urinary Incontinence
  2.4.4 Others
  2.4.5 Artificial Urinary Sphincter Sales by Clinical Application
    2.4.5.1 Global Artificial Urinary Sphincter Sales Market Share by Clinical Application (2021-2026)
    2.4.5.2 Global Artificial Urinary Sphincter Revenue and Market Share by Clinical Application (2021-2026)
    2.4.5.3 Global Artificial Urinary Sphincter Sale Price by Clinical Application (2021-2026)
2.5 Artificial Urinary Sphincter Segment by Application
  2.5.1 Public and University Hospitals
  2.5.2 Private Hospitals
  2.5.3 Specialty Urology Centers and Ambulatory Surgical Centers
  2.5.4 Others
  2.5.5 Artificial Urinary Sphincter Sales by Application
    2.5.5.1 Global Artificial Urinary Sphincter Sale Market Share by Application (2021-2026)
    2.5.5.2 Global Artificial Urinary Sphincter Revenue and Market Share by Application (2021-2026)
    2.5.5.3 Global Artificial Urinary Sphincter Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Artificial Urinary Sphincter Breakdown Data by Company
  3.1.1 Global Artificial Urinary Sphincter Annual Sales by Company (2021-2026)
  3.1.2 Global Artificial Urinary Sphincter Sales Market Share by Company (2021-2026)
3.2 Global Artificial Urinary Sphincter Annual Revenue by Company (2021-2026)
  3.2.1 Global Artificial Urinary Sphincter Revenue by Company (2021-2026)
  3.2.2 Global Artificial Urinary Sphincter Revenue Market Share by Company (2021-2026)
3.3 Global Artificial Urinary Sphincter Sale Price by Company
3.4 Key Manufacturers Artificial Urinary Sphincter Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Artificial Urinary Sphincter Product Location Distribution
  3.4.2 Players Artificial Urinary Sphincter Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ARTIFICIAL URINARY SPHINCTER BY GEOGRAPHIC REGION

4.1 World Historic Artificial Urinary Sphincter Market Size by Geographic Region (2021-2026)
  4.1.1 Global Artificial Urinary Sphincter Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Artificial Urinary Sphincter Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Artificial Urinary Sphincter Market Size by Country/Region (2021-2026)
  4.2.1 Global Artificial Urinary Sphincter Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Artificial Urinary Sphincter Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artificial Urinary Sphincter Sales Growth
4.4 APAC Artificial Urinary Sphincter Sales Growth
4.5 Europe Artificial Urinary Sphincter Sales Growth
4.6 Middle East & Africa Artificial Urinary Sphincter Sales Growth

5 AMERICAS

5.1 Americas Artificial Urinary Sphincter Sales by Country
  5.1.1 Americas Artificial Urinary Sphincter Sales by Country (2021-2026)
  5.1.2 Americas Artificial Urinary Sphincter Revenue by Country (2021-2026)
5.2 Americas Artificial Urinary Sphincter Sales by Type (2021-2026)
5.3 Americas Artificial Urinary Sphincter Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Artificial Urinary Sphincter Sales by Region
  6.1.1 APAC Artificial Urinary Sphincter Sales by Region (2021-2026)
  6.1.2 APAC Artificial Urinary Sphincter Revenue by Region (2021-2026)
6.2 APAC Artificial Urinary Sphincter Sales by Type (2021-2026)
6.3 APAC Artificial Urinary Sphincter Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Artificial Urinary Sphincter by Country
  7.1.1 Europe Artificial Urinary Sphincter Sales by Country (2021-2026)
  7.1.2 Europe Artificial Urinary Sphincter Revenue by Country (2021-2026)
7.2 Europe Artificial Urinary Sphincter Sales by Type (2021-2026)
7.3 Europe Artificial Urinary Sphincter Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Artificial Urinary Sphincter by Country
  8.1.1 Middle East & Africa Artificial Urinary Sphincter Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Artificial Urinary Sphincter Revenue by Country (2021-2026)
8.2 Middle East & Africa Artificial Urinary Sphincter Sales by Type (2021-2026)
8.3 Middle East & Africa Artificial Urinary Sphincter Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Urinary Sphincter
10.3 Manufacturing Process Analysis of Artificial Urinary Sphincter
10.4 Industry Chain Structure of Artificial Urinary Sphincter

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Artificial Urinary Sphincter Distributors
11.3 Artificial Urinary Sphincter Customer

12 WORLD FORECAST REVIEW FOR ARTIFICIAL URINARY SPHINCTER BY GEOGRAPHIC REGION

12.1 Global Artificial Urinary Sphincter Market Size Forecast by Region
  12.1.1 Global Artificial Urinary Sphincter Forecast by Region (2027-2032)
  12.1.2 Global Artificial Urinary Sphincter Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Artificial Urinary Sphincter Forecast by Type (2027-2032)
12.7 Global Artificial Urinary Sphincter Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Boston Scientific Corporation
  13.1.1 Boston Scientific Corporation Company Information
  13.1.2 Boston Scientific Corporation Artificial Urinary Sphincter Product Portfolios and Specifications
  13.1.3 Boston Scientific Corporation Artificial Urinary Sphincter Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Boston Scientific Corporation Main Business Overview
  13.1.5 Boston Scientific Corporation Latest Developments
13.2 ZSI Surgical Implants S.R.L.
  13.2.1 ZSI Surgical Implants S.R.L. Company Information
  13.2.2 ZSI Surgical Implants S.R.L. Artificial Urinary Sphincter Product Portfolios and Specifications
  13.2.3 ZSI Surgical Implants S.R.L. Artificial Urinary Sphincter Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 ZSI Surgical Implants S.R.L. Main Business Overview
  13.2.5 ZSI Surgical Implants S.R.L. Latest Developments
13.3 Rigicon, Inc.
  13.3.1 Rigicon, Inc. Company Information
  13.3.2 Rigicon, Inc. Artificial Urinary Sphincter Product Portfolios and Specifications
  13.3.3 Rigicon, Inc. Artificial Urinary Sphincter Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Rigicon, Inc. Main Business Overview
  13.3.5 Rigicon, Inc. Latest Developments
13.4 Promedon S.A.
  13.4.1 Promedon S.A. Company Information
  13.4.2 Promedon S.A. Artificial Urinary Sphincter Product Portfolios and Specifications
  13.4.3 Promedon S.A. Artificial Urinary Sphincter Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Promedon S.A. Main Business Overview
  13.4.5 Promedon S.A. Latest Developments
13.5 GT Urological
  13.5.1 GT Urological Company Information
  13.5.2 GT Urological Artificial Urinary Sphincter Product Portfolios and Specifications
  13.5.3 GT Urological Artificial Urinary Sphincter Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 GT Urological Main Business Overview
  13.5.5 GT Urological Latest Developments
13.6 UroMems S.A.S.
  13.6.1 UroMems S.A.S. Company Information
  13.6.2 UroMems S.A.S. Artificial Urinary Sphincter Product Portfolios and Specifications
  13.6.3 UroMems S.A.S. Artificial Urinary Sphincter Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 UroMems S.A.S. Main Business Overview
  13.6.5 UroMems S.A.S. Latest Developments
13.7 Carvolix (formerly Affluent Medical)
  13.7.1 Carvolix (formerly Affluent Medical) Company Information
  13.7.2 Carvolix (formerly Affluent Medical) Artificial Urinary Sphincter Product Portfolios and Specifications
  13.7.3 Carvolix (formerly Affluent Medical) Artificial Urinary Sphincter Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Carvolix (formerly Affluent Medical) Main Business Overview
  13.7.5 Carvolix (formerly Affluent Medical) Latest Developments
13.8 RELIEF srl
  13.8.1 RELIEF srl Company Information
  13.8.2 RELIEF srl Artificial Urinary Sphincter Product Portfolios and Specifications
  13.8.3 RELIEF srl Artificial Urinary Sphincter Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 RELIEF srl Main Business Overview
  13.8.5 RELIEF srl Latest Developments
13.9 Myopowers
  13.9.1 Myopowers Company Information
  13.9.2 Myopowers Artificial Urinary Sphincter Product Portfolios and Specifications
  13.9.3 Myopowers Artificial Urinary Sphincter Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Myopowers Main Business Overview
  13.9.5 Myopowers Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Artificial Urinary Sphincter Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Artificial Urinary Sphincter Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-Adjustable
Table 4. Major Players of Percutaneously Adjustable
Table 5. Major Players of Electronically Programmable
Table 6. Global Artificial Urinary Sphincter Sales by Type (2021-2026) & (K Units)
Table 7. Global Artificial Urinary Sphincter Sales Market Share by Type (2021-2026)
Table 8. Global Artificial Urinary Sphincter Revenue by Type (2021-2026) & ($ million)
Table 9. Global Artificial Urinary Sphincter Revenue Market Share by Type (2021-2026)
Table 10. Global Artificial Urinary Sphincter Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Passive Hydraulic Compression
Table 12. Major Players of Active Electromechanical Occlusion
Table 13. Major Players of Others
Table 14. Global Artificial Urinary Sphincter Sales by Actuation Mechanism (2021-2026) & (K Units)
Table 15. Global Artificial Urinary Sphincter Sales Market Share by Actuation Mechanism (2021-2026)
Table 16. Global Artificial Urinary Sphincter Revenue by Actuation Mechanism (2021-2026) & ($ million)
Table 17. Global Artificial Urinary Sphincter Revenue Market Share by Actuation Mechanism (2021-2026)
Table 18. Global Artificial Urinary Sphincter Sale Price by Actuation Mechanism (2021-2026) & (US$/Unit)
Table 19. Major Players of Male Post-Prostate Treatment Stress Urinary Incontinence
Table 20. Major Players of Male Neurogenic, Traumatic and Other Sphincter Deficiency
Table 21. Major Players of Female and Pediatric Severe Stress Urinary Incontinence
Table 22. Major Players of Others
Table 23. Global Artificial Urinary Sphincter Sales by Clinical Application (2021-2026) & (K Units)
Table 24. Global Artificial Urinary Sphincter Sales Market Share by Clinical Application (2021-2026)
Table 25. Global Artificial Urinary Sphincter Revenue by Clinical Application (2021-2026) & ($ million)
Table 26. Global Artificial Urinary Sphincter Revenue Market Share by Clinical Application (2021-2026)
Table 27. Global Artificial Urinary Sphincter Sale Price by Clinical Application (2021-2026) & (US$/Unit)
Table 28. Global Artificial Urinary Sphincter Sale by Application (2021-2026) & (K Units)
Table 29. Global Artificial Urinary Sphincter Sale Market Share by Application (2021-2026)
Table 30. Global Artificial Urinary Sphincter Revenue by Application (2021-2026) & ($ million)
Table 31. Global Artificial Urinary Sphincter Revenue Market Share by Application (2021-2026)
Table 32. Global Artificial Urinary Sphincter Sale Price by Application (2021-2026) & (US$/Unit)
Table 33. Global Artificial Urinary Sphincter Sales by Company (2021-2026) & (K Units)
Table 34. Global Artificial Urinary Sphincter Sales Market Share by Company (2021-2026)
Table 35. Global Artificial Urinary Sphincter Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Artificial Urinary Sphincter Revenue Market Share by Company (2021-2026)
Table 37. Global Artificial Urinary Sphincter Sale Price by Company (2021-2026) & (US$/Unit)
Table 38. Key Manufacturers Artificial Urinary Sphincter Producing Area Distribution and Sales Area
Table 39. Players Artificial Urinary Sphincter Products Offered
Table 40. Artificial Urinary Sphincter Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Artificial Urinary Sphincter Sales by Geographic Region (2021-2026) & (K Units)
Table 44. Global Artificial Urinary Sphincter Sales Market Share Geographic Region (2021-2026)
Table 45. Global Artificial Urinary Sphincter Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Artificial Urinary Sphincter Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Artificial Urinary Sphincter Sales by Country/Region (2021-2026) & (K Units)
Table 48. Global Artificial Urinary Sphincter Sales Market Share by Country/Region (2021-2026)
Table 49. Global Artificial Urinary Sphincter Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Artificial Urinary Sphincter Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Artificial Urinary Sphincter Sales by Country (2021-2026) & (K Units)
Table 52. Americas Artificial Urinary Sphincter Sales Market Share by Country (2021-2026)
Table 53. Americas Artificial Urinary Sphincter Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Artificial Urinary Sphincter Sales by Type (2021-2026) & (K Units)
Table 55. Americas Artificial Urinary Sphincter Sales by Application (2021-2026) & (K Units)
Table 56. APAC Artificial Urinary Sphincter Sales by Region (2021-2026) & (K Units)
Table 57. APAC Artificial Urinary Sphincter Sales Market Share by Region (2021-2026)
Table 58. APAC Artificial Urinary Sphincter Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Artificial Urinary Sphincter Sales by Type (2021-2026) & (K Units)
Table 60. APAC Artificial Urinary Sphincter Sales by Application (2021-2026) & (K Units)
Table 61. Europe Artificial Urinary Sphincter Sales by Country (2021-2026) & (K Units)
Table 62. Europe Artificial Urinary Sphincter Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Artificial Urinary Sphincter Sales by Type (2021-2026) & (K Units)
Table 64. Europe Artificial Urinary Sphincter Sales by Application (2021-2026) & (K Units)
Table 65. Middle East & Africa Artificial Urinary Sphincter Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Artificial Urinary Sphincter Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Artificial Urinary Sphincter Sales by Type (2021-2026) & (K Units)
Table 68. Middle East & Africa Artificial Urinary Sphincter Sales by Application (2021-2026) & (K Units)
Table 69. Key Market Drivers & Growth Opportunities of Artificial Urinary Sphincter
Table 70. Key Market Challenges & Risks of Artificial Urinary Sphincter
Table 71. Key Industry Trends of Artificial Urinary Sphincter
Table 72. Artificial Urinary Sphincter Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Artificial Urinary Sphincter Distributors List
Table 75. Artificial Urinary Sphincter Customer List
Table 76. Global Artificial Urinary Sphincter Sales Forecast by Region (2027-2032) & (K Units)
Table 77. Global Artificial Urinary Sphincter Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Artificial Urinary Sphincter Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Americas Artificial Urinary Sphincter Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Artificial Urinary Sphincter Sales Forecast by Region (2027-2032) & (K Units)
Table 81. APAC Artificial Urinary Sphincter Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Artificial Urinary Sphincter Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Europe Artificial Urinary Sphincter Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Artificial Urinary Sphincter Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Middle East & Africa Artificial Urinary Sphincter Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Artificial Urinary Sphincter Sales Forecast by Type (2027-2032) & (K Units)
Table 87. Global Artificial Urinary Sphincter Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Artificial Urinary Sphincter Sales Forecast by Application (2027-2032) & (K Units)
Table 89. Global Artificial Urinary Sphincter Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Boston Scientific Corporation Basic Information, Artificial Urinary Sphincter Manufacturing Base, Sales Area and Its Competitors
Table 91. Boston Scientific Corporation Artificial Urinary Sphincter Product Portfolios and Specifications
Table 92. Boston Scientific Corporation Artificial Urinary Sphincter Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Boston Scientific Corporation Main Business
Table 94. Boston Scientific Corporation Latest Developments
Table 95. ZSI Surgical Implants S.R.L. Basic Information, Artificial Urinary Sphincter Manufacturing Base, Sales Area and Its Competitors
Table 96. ZSI Surgical Implants S.R.L. Artificial Urinary Sphincter Product Portfolios and Specifications
Table 97. ZSI Surgical Implants S.R.L. Artificial Urinary Sphincter Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. ZSI Surgical Implants S.R.L. Main Business
Table 99. ZSI Surgical Implants S.R.L. Latest Developments
Table 100. Rigicon, Inc. Basic Information, Artificial Urinary Sphincter Manufacturing Base, Sales Area and Its Competitors
Table 101. Rigicon, Inc. Artificial Urinary Sphincter Product Portfolios and Specifications
Table 102. Rigicon, Inc. Artificial Urinary Sphincter Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Rigicon, Inc. Main Business
Table 104. Rigicon, Inc. Latest Developments
Table 105. Promedon S.A. Basic Information, Artificial Urinary Sphincter Manufacturing Base, Sales Area and Its Competitors
Table 106. Promedon S.A. Artificial Urinary Sphincter Product Portfolios and Specifications
Table 107. Promedon S.A. Artificial Urinary Sphincter Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Promedon S.A. Main Business
Table 109. Promedon S.A. Latest Developments
Table 110. GT Urological Basic Information, Artificial Urinary Sphincter Manufacturing Base, Sales Area and Its Competitors
Table 111. GT Urological Artificial Urinary Sphincter Product Portfolios and Specifications
Table 112. GT Urological Artificial Urinary Sphincter Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. GT Urological Main Business
Table 114. GT Urological Latest Developments
Table 115. UroMems S.A.S. Basic Information, Artificial Urinary Sphincter Manufacturing Base, Sales Area and Its Competitors
Table 116. UroMems S.A.S. Artificial Urinary Sphincter Product Portfolios and Specifications
Table 117. UroMems S.A.S. Artificial Urinary Sphincter Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. UroMems S.A.S. Main Business
Table 119. UroMems S.A.S. Latest Developments
Table 120. Carvolix (formerly Affluent Medical) Basic Information, Artificial Urinary Sphincter Manufacturing Base, Sales Area and Its Competitors
Table 121. Carvolix (formerly Affluent Medical) Artificial Urinary Sphincter Product Portfolios and Specifications
Table 122. Carvolix (formerly Affluent Medical) Artificial Urinary Sphincter Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Carvolix (formerly Affluent Medical) Main Business
Table 124. Carvolix (formerly Affluent Medical) Latest Developments
Table 125. RELIEF srl Basic Information, Artificial Urinary Sphincter Manufacturing Base, Sales Area and Its Competitors
Table 126. RELIEF srl Artificial Urinary Sphincter Product Portfolios and Specifications
Table 127. RELIEF srl Artificial Urinary Sphincter Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. RELIEF srl Main Business
Table 129. RELIEF srl Latest Developments
Table 130. Myopowers Basic Information, Artificial Urinary Sphincter Manufacturing Base, Sales Area and Its Competitors
Table 131. Myopowers Artificial Urinary Sphincter Product Portfolios and Specifications
Table 132. Myopowers Artificial Urinary Sphincter Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Myopowers Main Business
Table 134. Myopowers Latest Developments

LIST OF FIGURES

Figure 1. Picture of Artificial Urinary Sphincter
Figure 2. Artificial Urinary Sphincter Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artificial Urinary Sphincter Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Artificial Urinary Sphincter Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Artificial Urinary Sphincter Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Artificial Urinary Sphincter Sales Market Share by Country/Region (2025)
Figure 10. Artificial Urinary Sphincter Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Non-Adjustable
Figure 12. Product Picture of Percutaneously Adjustable
Figure 13. Product Picture of Electronically Programmable
Figure 14. Global Artificial Urinary Sphincter Sales Market Share by Type in 2026
Figure 15. Global Artificial Urinary Sphincter Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Passive Hydraulic Compression
Figure 17. Product Picture of Active Electromechanical Occlusion
Figure 18. Product Picture of Others
Figure 19. Global Artificial Urinary Sphincter Sales Market Share by Actuation Mechanism in 2026
Figure 20. Global Artificial Urinary Sphincter Revenue Market Share by Actuation Mechanism (2021-2026)
Figure 21. Product Picture of Male Post-Prostate Treatment Stress Urinary Incontinence
Figure 22. Product Picture of Male Neurogenic, Traumatic and Other Sphincter Deficiency
Figure 23. Product Picture of Female and Pediatric Severe Stress Urinary Incontinence
Figure 24. Product Picture of Others
Figure 25. Global Artificial Urinary Sphincter Sales Market Share by Clinical Application in 2026
Figure 26. Global Artificial Urinary Sphincter Revenue Market Share by Clinical Application (2021-2026)
Figure 27. Artificial Urinary Sphincter Consumed in Public and University Hospitals
Figure 28. Global Artificial Urinary Sphincter Market: Public and University Hospitals (2021-2026) & (K Units)
Figure 29. Artificial Urinary Sphincter Consumed in Private Hospitals
Figure 30. Global Artificial Urinary Sphincter Market: Private Hospitals (2021-2026) & (K Units)
Figure 31. Artificial Urinary Sphincter Consumed in Specialty Urology Centers and Ambulatory Surgical Centers
Figure 32. Global Artificial Urinary Sphincter Market: Specialty Urology Centers and Ambulatory Surgical Centers (2021-2026) & (K Units)
Figure 33. Artificial Urinary Sphincter Consumed in Others
Figure 34. Global Artificial Urinary Sphincter Market: Others (2021-2026) & (K Units)
Figure 35. Global Artificial Urinary Sphincter Sale Market Share by Application (2025)
Figure 36. Global Artificial Urinary Sphincter Revenue Market Share by Application in 2025
Figure 37. Artificial Urinary Sphincter Sales by Company in 2025 (K Units)
Figure 38. Global Artificial Urinary Sphincter Sales Market Share by Company in 2025
Figure 39. Artificial Urinary Sphincter Revenue by Company in 2025 ($ millions)
Figure 40. Global Artificial Urinary Sphincter Revenue Market Share by Company in 2025
Figure 41. Global Artificial Urinary Sphincter Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Artificial Urinary Sphincter Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Artificial Urinary Sphincter Sales 2021-2026 (K Units)
Figure 44. Americas Artificial Urinary Sphincter Revenue 2021-2026 ($ millions)
Figure 45. APAC Artificial Urinary Sphincter Sales 2021-2026 (K Units)
Figure 46. APAC Artificial Urinary Sphincter Revenue 2021-2026 ($ millions)
Figure 47. Europe Artificial Urinary Sphincter Sales 2021-2026 (K Units)
Figure 48. Europe Artificial Urinary Sphincter Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Artificial Urinary Sphincter Sales 2021-2026 (K Units)
Figure 50. Middle East & Africa Artificial Urinary Sphincter Revenue 2021-2026 ($ millions)
Figure 51. Americas Artificial Urinary Sphincter Sales Market Share by Country in 2025
Figure 52. Americas Artificial Urinary Sphincter Revenue Market Share by Country (2021-2026)
Figure 53. Americas Artificial Urinary Sphincter Sales Market Share by Type (2021-2026)
Figure 54. Americas Artificial Urinary Sphincter Sales Market Share by Application (2021-2026)
Figure 55. United States Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Artificial Urinary Sphincter Sales Market Share by Region in 2025
Figure 60. APAC Artificial Urinary Sphincter Revenue Market Share by Region (2021-2026)
Figure 61. APAC Artificial Urinary Sphincter Sales Market Share by Type (2021-2026)
Figure 62. APAC Artificial Urinary Sphincter Sales Market Share by Application (2021-2026)
Figure 63. China Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 67. India Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Artificial Urinary Sphincter Sales Market Share by Country in 2025
Figure 71. Europe Artificial Urinary Sphincter Revenue Market Share by Country (2021-2026)
Figure 72. Europe Artificial Urinary Sphincter Sales Market Share by Type (2021-2026)
Figure 73. Europe Artificial Urinary Sphincter Sales Market Share by Application (2021-2026)
Figure 74. Germany Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 75. France Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Artificial Urinary Sphincter Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Artificial Urinary Sphincter Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Artificial Urinary Sphincter Sales Market Share by Application (2021-2026)
Figure 82. Egypt Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Artificial Urinary Sphincter Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Artificial Urinary Sphincter in 2026
Figure 88. Manufacturing Process Analysis of Artificial Urinary Sphincter
Figure 89. Industry Chain Structure of Artificial Urinary Sphincter
Figure 90. Channels of Distribution
Figure 91. Global Artificial Urinary Sphincter Sales Market Forecast by Region (2027-2032)
Figure 92. Global Artificial Urinary Sphincter Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Artificial Urinary Sphincter Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Artificial Urinary Sphincter Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Artificial Urinary Sphincter Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Artificial Urinary Sphincter Revenue Market Share Forecast by Application (2027-2032)


More Publications

Global Metal Biliary Stent Market Growth 2025-2031 US$ 3,660.00 March 2025 86 pages
Global Peptic Ulcer Drugs Market Growth 2024-2030 US$ 3,660.00 January 2024 115 pages
Global Micro-needling Unit Market Growth 2025-2031 US$ 3,660.00 December 2024 119 pages